CSPC PHARMA (01093): Li Chunlei appointed as authorized representative

CSPC PHARMA (01093) announced that, effective November 4, 2025, Mr. Pan Weidong resigned as an executive director of the company and will no longer serve as the authorized representative of the company pursuant to Rule 3.05 of the Listing Rules of the Hong Kong Stock Exchange due to the need for more time to deal with his personal affairs; Dr. Li Chunlei, an executive director of the company, has been appointed as the authorized representative.